Giri et al. present a case report involving a patient with metachronous low-volume metastatic hormone-sensitive prostate cancer (mHSPC) who declined standard treatments such as androgen deprivation ...
Journal of Nuclear Medicine September 2025, jnumed.125.270267; DOI: https://doi.org/10.2967/jnumed.125.270267 ...
Primary sclerosing cholangitis (PSC) is a chronic cholestatic disease marked by fibrosis, strictures, and a high risk for developing cholangiocarcinoma (CCC). Recognition of CCC in PSC remains a ...
Journal of Nuclear Medicine September 2025, jnumed.125.270807; DOI: https://doi.org/10.2967/jnumed.125.270807 ...
Journal of Nuclear Medicine August 2025, jnumed.125.270318; DOI: https://doi.org/10.2967/jnumed.125.270318 ...
Journal of Nuclear Medicine August 2025, jnumed.125.269795; DOI: https://doi.org/10.2967/jnumed.125.269795 ...
Journal of Nuclear Medicine August 2025, jnumed.124.268841; DOI: https://doi.org/10.2967/jnumed.124.268841 ...
Journal of Nuclear Medicine August 2025, jnumed.124.269234; DOI: https://doi.org/10.2967/jnumed.124.269234 ...
Journal of Nuclear Medicine July 2025, jnumed.125.269729; DOI: https://doi.org/10.2967/jnumed.125.269729 ...
Journal of Nuclear Medicine July 2025, jnumed.125.270069; DOI: https://doi.org/10.2967/jnumed.125.270069 ...
Journal of Nuclear Medicine July 2025, jnumed.125.270252; DOI: https://doi.org/10.2967/jnumed.125.270252 ...
Journal of Nuclear Medicine July 2025, jnumed.125.270234; DOI: https://doi.org/10.2967/jnumed.125.270234 ...